Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Injectables Protein-Based Nanodiscs in Cancer Drug Delivery: From Bench to Clinical Potential.

AAPS PharmSciTech·2025

Same author

Long-term hydroxychloroquine use resulting in cardiomyopathy and conduction abnormalities: a case report.

European heart journal. Case reports·2025

Same author

Recommendations on biomarker assay validation (BAV) in tissues by GCC.

Bioanalysis·2025

Same author

Clinical presentations of post ischemic and post traumatic brain injury scars associated seizures.

Neurological research·2025

Same author

Effect of E7777 Immunogenicity on Pharmacokinetics, Efficacy, and Safety in Adult Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.

Clinical and translational science·2025

Same author

Revolutionizing Drug Development: Harnessing Artificial Intelligence in Pharmaceutical Sciences.

Current drug discovery technologies·2025

Same journal

A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1.

Bioanalysis·2026

Same journal

ADA assays for high-dose biologics: redefining drug tolerance through clinical insights.

Bioanalysis·2026

Same journal

Comparison of SERS spectral data sets of blood serum samples of hypopharyngeal cancer using silver and gold nanoparticles as substrates.

Bioanalysis·2026

Same journal

The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and bioanalytical applications.

Bioanalysis·2026

Same journal

Simultaneous quantification of D-penicillamine, D-penicillamine disulfide, and L-cysteine-D-penicillamine disulfide in human plasma: optimization of sample preparation and mass spectrometry procedures to support bioequivalence studies.

Bioanalysis·2026

Same journal

Development and preliminary clinical application of a time-resolved fluoroimmunoassay for anti-rituximab antibodies in membranous nephropathy.

Bioanalysis·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Method transfer for ligand-binding assays: recommendations for best practice.

Danielle DeSimone¹, Judy Y Shih, Han C Gunn

¹Department of Pharmacokinetic & Drug Metabolism, Amgen Inc., Thousand Oaks, CA 91320, USA.

|September 28, 2011

Summary

This summary is machine-generated.

Transferring bioanalytical methods for large molecules is crucial for clinical trials. This review offers strategies for successful ligand-binding assay method transfer and validation, ensuring efficiency and timely drug development.

More Related Videos

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Published on: August 15, 2013

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Published on: August 15, 2013

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

Area of Science:

Biotechnology
Pharmaceutical Analysis
Clinical Diagnostics

Background:

Bioanalytical method transfer is essential for supporting clinical trials, especially with increasing FDA submissions for large-molecule therapeutics.
Ligand-binding assays (LBAs) are the primary methods for quantifying proteins, vital for biomarker and pharmacokinetic assessments.
The growing demand for large-molecule bioanalytical support necessitates efficient and reliable method transfer processes.

Purpose of the Study:

To provide a comprehensive overview of ligand-binding assay method transfer for large molecules.
To outline critical parameters for partial method validation during assay transfer.
To present a strategic approach for maximizing the success rate of bioanalytical method transfers.

Main Methods:

Review of current scientific publications on bioanalytical method transfer.
Synthesis of authors' practical experiences and best practices.
Identification of key parameters for successful partial method validation.

Main Results:

Established a clear understanding of the challenges and requirements for LBA method transfer.
Defined essential parameters for partial method validation to ensure assay reliability post-transfer.
Outlined a strategic framework to enhance the efficiency and success of method transfer processes.

Conclusions:

Successful ligand-binding assay method transfer is critical for efficient clinical trial support and timely drug approval.
Adherence to specific validation parameters and strategic planning are key to overcoming transfer challenges.
Implementing the recommended strategies can improve laboratory efficiency, foster collaborations, and meet program timelines.